Skip to content

Vitamin B6 (P5P)

The active, ready-to-use form of vitamin B6 — a cofactor for neurotransmitter synthesis, homocysteine metabolism and hormone regulation.

  • CategoryVitamins
  • FormPyridoxal-5-Phosphate
  • EvidenceClinical trials on file

Where to get Vitamin B6 (P5P)

Thorne
Pyridoxal 5'-Phosphate

10% off is applied automatically through Cam’s partner link, so there is no code to enter.

Shop at Thorne

The short version

  • What it doesPyridoxal 5'-phosphate is the busiest cofactor in human metabolism, and that breadth is why nothing on this page has a clean endpoint. More than 140 enzyme activities depend on it, nearly all of them acting on amino acids: transaminases, decarboxylases, racemases and the enzymes of one-carbon and heme synthesis.
  • Who it is forNeurotransmitter/mood support, PMS, methylation/homocysteine.
  • What to watchPeripheral neuropathy is the defining risk of this vitamin — numbness, tingling and unsteadiness from sustained high intake. It is the clearest example of a water-soluble vitamin that is not harmless in excess.

How Vitamin B6 (P5P) works

Pyridoxal-5-phosphate is the active coenzyme form and it is required by over 140 enzymes — more than any other vitamin cofactor. The ones worth naming: aromatic L-amino acid decarboxylase, which converts 5-HTP to serotonin and L-DOPA to dopamine; cystathionine beta-synthase, which clears homocysteine down the transsulfuration route to glutathione; and ALA synthase, the first committed step of heme synthesis.

Read the rest of how it works

Supplying P5P skips the hepatic conversion step that pyridoxine hydrochloride requires.

Vitamin B6 (P5P): serving, timing and spacing

Suggested serving
As directed with food.
How often
Daily
When
With food
Spacing that matters for safety
Above 100 mg long-term causes peripheral neuropathy - the one B vitamin with a real ceiling

Good to know: Very high-dose B6 over long periods can cause reversible nerve tingling — stay in sensible ranges.

Research on Vitamin B6 (P5P)4 evidence notes: clinical, correlative, theoretical

Each note sits under the kind of evidence it stands on. A thin or missing trial means nobody has run it yet, not that it doesn’t work. How the evidence tiers work

Human clinical evidence

  • Corrects B6 deficiency and lowers homocysteine (with folate/B12).

  • RCT support for reducing PMS symptoms and pregnancy-related nausea.

Correlative data

  • Low B6 status is associated with mood disturbance and elevated homocysteine.

Theoretical / extrapolated benefits

  • Active-form superiority is plausible; most trials used regular B6, so the edge is inferred.

Sources read for this page

  • Muhamad R. The Role of Vitamin B6 in Peripheral Neuropathy: A Systematic Review. Nutrients 2023 · PMID 37447150
  • Kastner U, et al. The human pyridoxal kinase, a plausible target for ginkgotoxin from Ginkgo biloba. FEBS Journal 2007 · PMID 17250738
  • Lee GH, et al. Zebrafish larvae exposed to ginkgotoxin exhibit seizure-like behavior that is relieved by pyridoxal-5'-phosphate, GABA and anti-epileptic drugs. Disease Models & Mechanisms 2012 · PMID 22736461
  • Clarke R, et al. Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals. Archives of Internal Medicine, 2010 · PMID 20937919
  • Kataria N. Effect of Vitamin B6, B9, and B12 Supplementation on Homocysteine Level and Cardiovascular Outcomes in Stroke Patients: A Meta-Analysis of Randomized Controlled Trials. Cureus 2021 · PMID 34123655
  • Guo L. Combined B-vitamin supplementation on homocysteine and vascular outcomes in coronary heart disease: a meta-analysis. Ann Med 2026 · PMID 41615824

Vitamin B6 (P5P), the deep readThe mechanism, cell to human, which form, how you would know

What Vitamin B6 (P5P) actually does

Pyridoxal 5'-phosphate is the busiest cofactor in human metabolism, and that breadth is why nothing on this page has a clean endpoint. More than 140 enzyme activities depend on it, nearly all of them acting on amino acids: transaminases, decarboxylases, racemases and the enzymes of one-carbon and heme synthesis. The chemistry is always the same — the aldehyde forms a Schiff base with the substrate's amino group and the pyridine ring acts as an electron sink to stabilize the carbanion.

The reactions a reader is likely to care about are the neurotransmitter ones. Glutamate decarboxylase makes GABA from glutamate; aromatic L-amino acid decarboxylase makes serotonin from 5-hydroxytryptophan and dopamine from L-DOPA; cystathionine beta-synthase and cystathionine gamma-lyase clear homocysteine down the transsulfuration arm toward cysteine. Every one of those needs pyridoxal 5'-phosphate and none of them is limited by it in a person eating food.

Every form converges on one enzyme, and it is a kinase. Pyridoxine, pyridoxal and pyridoxamine are all phosphorylated by pyridoxal kinase, and the phosphorylated forms are interconverted by pyridoxine 5'-phosphate oxidase. Pyridoxal kinase is the bottleneck for the whole vitamin, and it is inhibitable: ginkgotoxin, 4'-O-methylpyridoxine from Ginkgo biloba, is a direct pyridoxal kinase inhibitor Kastner 2007, and the seizures it produces are relieved by pyridoxal 5'-phosphate Lee 2012. That is a worked example of a cofactor deficiency created downstream of intake rather than by it.

The plasma marker is not a measure of intake, which is the surrogate problem here. Plasma pyridoxal 5'-phosphate is the standard status test, and it falls during inflammation independently of B6 intake — redistribution to sites of inflammation and increased utilization by the transsulfuration pathway both contribute. A low plasma PLP in an inflamed person is at least as likely to be a consequence of the illness as a cause of it.

And there is a paradox at the top of the dose range. The same molecule that is essential in micrograms is neurotoxic in hundreds of milligrams, and the toxicity belongs to pyridoxine specifically. The leading explanation is that excess unphosphorylated pyridoxine competes with pyridoxal 5'-phosphate at enzyme active sites, producing a functional B6 deficiency at a very high B6 intake Muhamad 2023.

Cell, rodent, human — and where it stops

Cell to human is short and well trodden. The human end has one reliable positive, one large negative and one dose-dependent harm.

In enzymology and in animals. Pyridoxal kinase inhibition by ginkgotoxin produces seizures in zebrafish larvae that pyridoxal 5'-phosphate reverses Lee 2012, which demonstrates the whole chain from cofactor availability to a neurological phenotype and back. Pyridoxine-dependent epilepsy in infants is the human version of an inborn block in the same pathway and responds to B6 dramatically. Deficiency biology is not in question.

In people the homocysteine arm behaves exactly as the pathway predicts and produces nothing. B6 supports the transsulfuration route out of homocysteine, so it is included in nearly every homocysteine-lowering regimen. Meta-analysis of B6, B9 and B12 in stroke patients confirms the homocysteine reduction and finds no corresponding cardiovascular benefit Kataria 2021, and the same conclusion emerges from pooled trials in coronary heart disease Guo 2026 and from the largest pooled analysis of the era Clarke 2010.

The obstacle to transfer is specific to B6 and worth naming separately from the folate story. B6's contribution to the homocysteine fall is small compared with folate's; where B6 changes homocysteine most is on a methionine load rather than in the fasting state. So the trials were testing a vitamin at a dose chosen for a marker it barely moves, against an endpoint the marker does not predict.

The one place a B6 supplement has a defensible symptomatic claim is nausea in pregnancy, where pyridoxine with or without doxylamine is a first-line option supported by randomized trials. That is a genuine outcome, at 10 to 25 mg three times daily, and it is not a nutritional argument at all.

And the harm transferred better than the benefit. A systematic review of vitamin B6 in peripheral neuropathy finds the literature dominated by reports of neuropathy CAUSED by supplementation rather than corrected by it, at doses well below the gram-level exposures of the original 1980s case series Muhamad 2023.

Vitamin B6 (P5P) — which form, and does it matter

Pyridoxal 5'-phosphate is sold as the form that skips a step, and it does not skip it. The phosphate group is polar and cannot cross the enterocyte membrane. Intestinal alkaline phosphatase dephosphorylates P5P in the gut lumen to pyridoxal, which is absorbed by passive diffusion and then rephosphorylated by pyridoxal kinase in the liver — the same kinase that pyridoxine has to use. A P5P capsule therefore arrives at the same bottleneck as a pyridoxine capsule, by a slightly different road.

Where the form choice may genuinely matter is the second enzyme. Converting pyridoxine phosphate to pyridoxal 5'-phosphate requires pyridoxine 5'-phosphate oxidase, a flavin-dependent enzyme whose activity depends on riboflavin status and which is defective in a rare inborn error. In a person with poor riboflavin status or that defect, supplying pyridoxal rather than pyridoxine bypasses a step that pyridoxine cannot. That is a real but narrow indication, and it is not the reason most P5P is sold.

The exposure numbers are the reason the toxicity exists. Absorption is passive, unsaturable and essentially complete across the supplemental range — there is no transporter to limit intake, which is unusual for a water-soluble vitamin and is why a 100 mg dose actually delivers 100 mg. Plasma pyridoxal 5'-phosphate has a half-life of roughly 10 to 20 days because it circulates bound to albumin, while free pyridoxine and its catabolite 4-pyridoxic acid undergo rapid renal clearance with a half-life of a few hours. Aldehyde oxidase performs the terminal oxidation to 4-pyridoxic acid; there is no meaningful cytochrome step and no first-pass limitation.

Those two half-lives are the practical lesson. The long-lived albumin-bound pool means a daily 100 mg dose accumulates for weeks before reaching steady state, so neuropathy appears months into a regimen rather than after a large dose, and it also means recovery after stopping is slow Muhamad 2023.

What a label does not tell the reader. Products declare milligrams of pyridoxine hydrochloride or of P5P without noting that the tolerable upper intake level is set on total B6 and that European authorities have revised it sharply downward. A 50 mg capsule taken alongside a B-complex and an energy drink is a common route to an intake nobody chose.

What would have to be true, and how you would know it was not

1. Plasma PLP will rise and it will not tell you much. Predict that a B6 measurement rises within 2 to 4 weeks on any form at supplemental dose. Predict also that in somebody with a raised hs-CRP, a low baseline PLP partly reflects the inflammation rather than the diet, so treat a low result as a prompt to measure hs-CRP rather than as a diagnosis.

2. Homocysteine falls a little and the fall belongs mostly to the folate in the bottle. Predict a modest homocysteine reduction on a B-complex and a much smaller one on B6 alone Kataria 2021. Retest at 8 to 12 weeks.

3. The prediction that cuts against the product. Predict that adding B6 to a cardiovascular prevention regimen produces no change in events, because that is what the pooled randomized evidence returns Clarke 2010 Guo 2026. A trial in a B6-deficient-by-PLP population showing event reduction would falsify this page and has never been attempted.

4. Predict the neurological read-out is a symptom, not a number, and set a stopping rule in advance. Numbness, pins and needles or unsteadiness starting in the feet is the presentation of pyridoxine neuropathy, and it appears after months rather than days Muhamad 2023. Predict that it does not occur below 10 mg a day and that it becomes plausible above 50 mg sustained. Any new sensory symptom on a B6-containing product is a reason to stop and total up every source.

5. Predict an interaction if levodopa is in the picture. Pyridoxine accelerates peripheral decarboxylation of levodopa by aromatic L-amino acid decarboxylase, reducing what reaches the brain, unless a peripheral decarboxylase inhibitor is co-administered. Predict a measurable loss of levodopa effect on unopposed pyridoxine, and none on modern combination therapy.

What nobody has tested yet

Nobody has established where the neuropathy threshold actually is. Case reports span 24 mg to several grams a day, the dose-duration relationship has never been characterized prospectively, and the upper intake levels set by different authorities differ by more than an order of magnitude Muhamad 2023. That is an unusually large uncertainty for a vitamin sold without restriction.

Nobody has tested the P5P claim in the population it is sold to. A randomized comparison of pyridoxine against P5P at equal molar dose, with plasma PLP and a functional marker as endpoints, in people with normal riboflavin status, has not been published. The entire premium for the active form rests on the pathway diagram.

Whether low plasma PLP in inflammation is worth correcting is unresolved. The association between low PLP and inflammatory disease is robust; no trial has established that repleting it changes the disease, and the reverse-causation explanation has never been excluded.

And the interaction with plant medicines that inhibit the kinase has never been studied in people. Ginkgotoxin's inhibition of pyridoxal kinase is established in vitro and in animals Kastner 2007 Lee 2012, and no clinical study has asked whether habitual ginkgo use alters B6 status in humans. Both products sit on the same shelf.

Vitamin B6 (P5P) — its own safety story, not its category's

This is a vitamin with a genuine, documented, dose-related neurotoxicity, and that is unusual enough to lead with. Chronic high-dose pyridoxine causes a sensory ganglionopathy: numbness and tingling beginning in the feet and hands, loss of vibration and position sense, and gait unsteadiness, with the motor system spared. It is usually reversible on stopping, and recovery takes months because of the long albumin-bound half-life Muhamad 2023.

The upper intake level has moved and most labels have not. The long-standing United States figure is 100 mg per day for adults. European reassessment has proposed a substantially lower number after reviewing the same neuropathy literature, and several national regulators have restricted over-the-counter strengths. Products at 50 and 100 mg remain widely sold in the United States.

The hidden-dose problem is worse here than for most vitamins. B6 is in B-complex products, in multivitamins, in magnesium formulas marketed for premenstrual symptoms, in energy drinks and in many nootropic blends, frequently at 10 to 50 mg each. The reported neuropathy cases are typically people who never bought a B6 product.

The interactions that matter. Levodopa without a decarboxylase inhibitor, as above. Phenytoin and phenobarbital concentrations can fall with high-dose B6. Isoniazid, hydralazine, penicillamine and cycloserine all form hydrazone complexes with pyridoxal and cause a B6 deficiency that is treated with B6 — the one common situation where high intake is deliberate and supervised.

Who should be careful. Anyone taking more than 25 mg a day from all sources without a specific reason; anyone with an existing peripheral neuropathy, in whom a new B6 supplement can worsen the picture that prompted it; and anyone on levodopa. Nothing here is medical advice or diagnosis, and these statements have not been evaluated by the Food and Drug Administration.

Vitamin B6 (P5P) safety basics3 points of its own

Its own safety story

  • Peripheral neuropathy is the defining risk of this vitamin — numbness, tingling and unsteadiness from sustained high intake. It is the clearest example of a water-soluble vitamin that is not harmless in excess.
  • The upper limit is 100 mg/day, and cases have occurred below it with long-term use. P5P is the active form and is not exempt.
  • Stop immediately and get reviewed if you develop tingling in the hands or feet. Reduces levodopa effectiveness; interacts with phenytoin.

Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor. Pharmacists are underused and free.

Bloodwork to run5 tests in one order, code CAMERON

Vitamin B6 (P5P) FAQ5 common questions

What is Vitamin B6 (P5P)?
The active, ready-to-use form of vitamin B6 — a cofactor for neurotransmitter synthesis, homocysteine metabolism and hormone regulation.
What is the suggested dose of Vitamin B6 (P5P)?
As directed with food. This is a general reference for education only. Statements have not been evaluated by the FDA and this is not medical advice.
Who is Vitamin B6 (P5P) for?
Neurotransmitter/mood support, PMS, methylation/homocysteine.
Which labs show whether Vitamin B6 (P5P) is doing anything?
Comprehensive Metabolic Panel (CMP), Homocysteine, Vitamin B12, Prolactin, Folate, Serum. Draw a baseline before you start, then recheck.
Where can I buy Vitamin B6 (P5P)?
Coach Cam sources Vitamin B6 (P5P) from Thorne, with 10% off applied automatically at checkout. Use the buy link on this page.
The Before-You-Stack Lab Kit cover

The free Before‑You‑Stack Lab Kit

The 12 labs I’d run before any protocol, what each one tells you, add-ons by goal and how to order them yourself. The PDF is yours straight away.

After that it is about two emails a week: a marker, a compound or a protocol. Unsubscribe in one click.

The full stack plan is inside Skool

This page covers what Vitamin B6 (P5P) is, what the research says and how people take it. Skool puts it in order alongside everything else you run, peptides included.

Free on this page

What Vitamin B6 (P5P) is and how it works · The serving, its basis, and its safety lines · The research and the bloodwork that shows it

  • What Vitamin B6 (P5P) is and how it works
  • The serving, its basis, and its safety lines
  • The research and the bloodwork that shows it

Members get

  • Vitamin B6 (P5P) in your full stack: what it runs with, and what it cancels out
  • Its place in 2 Protocol Blueprints (Sleep, Female Hormone), week by week
  • The retest plan: Comprehensive Metabolic Panel (CMP) baseline, the recheck, what a change means
Join Skool $10/mo1,500+ members, 5.0 rating from 15 reviews. Cancel anytime.
The members' Prep Bench in Skool: the compound finder (no dose shown)
The members’ Prep Bench

Want it built around you?

The coaching app, with sample data

1-on-1 coaching with Cam

Your plan, your bloodwork and your check-ins, built around you.

Research Protocol $150/mo · Full Coaching $250/mo

See coaching

One question? Book a 15-minute consult

A call with Cam on the one thing you are stuck on.

$75 per call

Book a consult

Educational reference only. Not medical advice. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure or prevent any disease. Some links are affiliate links; Cam may earn a commission at no extra cost to you. Medical disclaimer & affiliate disclosure

Buy with 10% offJoin Skool